Noncovalent interaction of α2-antiplasmin with fibrin(ogen): Localization of α2-antiplasmin-binding sites

Biochemistry

Volumn 49, Issue 35, 2010, Pages 7643-7651

  Tsurupa, Galina ^a   Yakovlev, Sergiy ^a   McKee, Patrick ^b   Medved, Leonid ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-PLASMIN; C-DOMAIN; COVALENT CROSSLINKING; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRIN CLOTS; INITIAL STAGES; NO BINDING; NON-COVALENT INTERACTION; SUB-DOMAINS; SUBDOMAIN;

BINDING ENERGY; BIOCHEMISTRY; D REGION; SURFACE PLASMON RESONANCE;

BINDING SITES;

ALPHA 2 ANTIPLASMIN; FIBRINOGEN; PLASMINOGEN; FIBRIN;

ARTICLE; BINDING SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRIN CLOT; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; CHEMISTRY; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ALPHA-2-ANTIPLASMIN; BINDING SITES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN; FIBRINOGEN; PROTEIN STRUCTURE, TERTIARY; SURFACE PLASMON RESONANCE;

EID: 77956161958     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi1010317     Document Type: Article

References (47)

1. Lijnen, H. R. (2001) Plasmin and matrix metalloproteinases in vascular remodeling Thromb. Haemostasis 86, 324-333
2. Lijnen, H. R. (2001) Elements of the fibrinolytic system Ann. N.Y. Acad. Sci. 936, 226-236
3. Rijken, D. C. and Lijnen, H. R. (2009) New insights into the molecular mechanisms of the fibrinolytic system J. Thromb. Haemostasis 7, 4-13
4. Medved, L. and Nieuwenhuizen, W. (2003) Molecular mechanisms of initiation of fibrinolysis by fibrin Thromb. Haemostasis 89, 409-419
5. 2-plasmin inhibitor associated with severe hemorrhagic tendency J. Clin. Invest. 63, 877-884
6. Aoki, N. (2005) The past, present and future of plasmin inhibitor Thromb. Res. 116, 455-464
7. 2-Antiplasmin and its deficiency: Fibrinolysis out of balance Haemophilia 14, 1250-1254
8. 2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis J. Biol. Chem. 251, 5956-5965
9. Coughlin, P. B. (2005) Antiplasmin: The forgotten serpin? FEBS J. 272, 4852-4857
10. 2-plasmin inhibitor in human plasma Biochem. J. 291, 623-625
11. 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells Biochem. Biophys. Res. Commun. 200, 417-422
12. 2-Antiplasmin: Potential therapeutic roles in fibrin survival and removal Curr. Med. Chem.: Cardiovasc. Hematol. Agents 2, 303-310
13. Lee, K. N., Jackson, K. W., Christiansen, V. J., Lee, C. S., Chun, J. G., and McKee, P. A. (2006) Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein Blood 107, 1397-1404
14. 2-plasmin inhibitor deduced from that of cDNA J. Biochem. 100, 1399-13402
15. 2- antiplasmin Blood 111, 2049-2052
16. 2-plasmin inhibitor J. Biochem. 99, 1699-1705
17. 2-plasmin inhibitor C-terminal peptide Biochemistry 42, 1078-1085
18. 2- plasmin inhibitor to fibrin by fibrin-stabilizing factor J. Clin. Invest. 65, 290-297
19. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis J. Clin. Invest. 69, 536-542
20. Lee, K. N., Jackson, K. W., Christiansen, V. J., Lee, C. S., Chun, J. G., and McKee, P. A. (2007) Why α-antiplasmin must be converted to a derivative form for optimal function J. Thromb. Haemostasis 5, 2095-2104
21. Henschen, A. and McDonagh, J. (1986) Fibrinogen, fibrin and factor XIII. In Blood Coagulation (Zwaal, R. F. A. and Hemker, H. C., Eds.) pp 171 - 241, Elsievier Science Publishers, Amsterdam.
22. Medved, L. and Weisel, J. W. (2009) Recommendations for nomenclature on fibrinogen and fibrin. Fibrinogen and Factor XIII Subcommittee of Scientific Standardization Committee of International Society on Thrombosis and Haemostasis J. Thromb. Haemostasis 7, 355-359
23. Tsurupa, G., Tsonev, L., and Medved, L. (2002) Structural organization of the fibrin(ogen) αC-domain Biochemistry 41, 6449-6459
24. Pizzo, S. V., Schwartz, M. L., Hill, R. L., and McKee, P. A. (1972) The effect of plasmin on the subunit structure of human fibrinogen J. Biol. Chem. 247, 636-645
25. Tsurupa, G. and Medved, L. (2001) Identification and characterization of novel tPA- and plasminogen- binding sites within fibrin(ogen) αC-domains Biochemistry 40, 801-808
26. Yakovlev, S., Makogonenko, E., Kurochkina, N., Nieuwenhuizen, W., Ingham, K., and Medved, L. (2000) Conversion of fibrinogen to fibrin: Mechanism of exposure of tPA- and plasminogen-binding sites Biochemistry 39, 15730-15741
27. Medved, L., Tsurupa, G., and Yakovlev, S. (2001) Conformational changes upon conversion of fibrinogen into fibrin. The mechanisms of exposure of cryptic sites Ann. N.Y. Acad. Sci. 936, 185-204
28. 2- antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: A new role for plasma factor XIII in fibrinolysis regulation J. Thromb. Haemostasis 6, 1565-1570
29. 2-plasmin inhibitor J. Biol. Chem. 261, 15591-15595
30. 2-antiplasmin to fibrin(ogen) J. Biol. Chem. 275, 24915-24920
31. Mosesson, M. W., Siebenlist, K. R., Hernandez, I., Wall, J. S., and Hainfeld, J. F. (2002) Fibrinogen assembly and crosslinking on a fibrin fragment E template Thromb. Haemostasis 87, 651-658
32. Makogonenko, E., Tsurupa, G., Ingham, K., and Medved, L. (2002) Interaction of fibrin(ogen) with fibronectin: Further characterization and localization of the fibronectin-binding site Biochemistry 41, 7907-7913
33. 2- antiplasmin inhibition of fibrin digestion Blood 103, 3783-3788
34. Yakovlev, S., Gorlatov, S., Ingham, K., and Medved, L. (2003) Interaction of fibrin(ogen) with heparin: Further characterization and localization of the heparin-binding site Biochemistry 42, 7709-7716
35. Tsurupa, G., Yakovlev, S., Lamanuzzi, L. B., Angles-Cano, E., and Medved, L. (2006) Interaction of fibrin(ogen) with apolipoprotein(a): Further characterization and identification of a novel lysine-dependent apolipoprotein(a)-binding site within the γ chain 287-411 region Biochemistry 45, 10624-10632
36. Tsurupa, G., Hantgan, R. R., Burton, R. A., Pechik, I., Tjandra, N., and Medved, L. (2009) Structure, stability, and interaction of the fibrin(ogen) αC-domains Biochemistry 48, 12191-12201
37. Matsuka, Y. V., Medved, L. V., Migliorini, M. M., and Ingham, K. C. (1996) Factor XIIIa-catalyzed cross-linking of recombinant αC fragments of human fibrinogen Biochemistry 35, 5810-5816
38. Gill, S. C. and von Hippel, P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data Anal. Biochem. 182, 319-326
39. Tsurupa, G., Ho-Tin-Noe, B., Angles-Cano, E., and Medved, L. (2003) Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) αC-domains J. Biol. Chem. 278, 37154-37159
40. Spraggon, G., Everse, S. J., and Doolittle, R. F. (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin Nature 389, 455-462
41. 2-antiplasmin and plasmin J. Biol. Chem. 254, 9291-9297
42. 2 in the γC-domain of fibrinogen Biochemistry 41, 12942-12951
43. 2 (Mac-1): Further characterization and identification of a novel binding region within the central domain of the fibrinogen γ-module Biochemistry 44, 617-626
44. 2-antiplasmin and in fibrinogen Biochim. Biophys. Acta 579, 142-154
45. 2-plasmin inhibitor Thromb. Res. 10, 851-856
46. Pointing, C. P., Marshall, J. M., and Cederholm-Williams, S. A. (1992) Plasminogen: Structural review Blood Coagulation Fibrinolysis 3, 605-614
47. Yang, Z., Kollman, J. M., Pandi, L., and Doolittle, R. F. (2001) Crystal structure of native chicken fibrinogen at 2.7 Å resolution Biochemistry 40, 12515-12523